Digital Health Startup Proton Intelligence Raises $6.95 million in Seed Funding

Proton Intelligence Inc., an Australia-based developer of a continuous potassium monitoring platform, raised $6.95 million in Seed funding.

The funding round was co-led by SOSV, We Venture Capital, Tenmile, LongeVC, 15th Rock, Exor, and Trampoline Venture Partners.

“We are proud to be the first institutional investor in Proton Intelligence,” said Mohan S. Iyer, General Partner at SOSV. “The team’s exceptional focus and relentless execution inspire confidence, and we are excited to continue to support them as they move into clinical validation.”

“This fundraising milestone represents a major leap forward for us,” said Dr. Sahan Ranamukhaarachchi, Founder and CEO of Proton Intelligence Inc. “We are immensely grateful for the trust and support of our investors, who share our vision of revolutionizing cardio-kidney-metabolic care. Their belief in our mission sees us funded through several clinical feasibility trials ahead of a pivotal study planned for 2026 and get closer to making CKM™ a reality for millions of patients.”

Proton Intelligence Inc. is headquartered in Vancouver, Canada, with R&D operations in Melbourne, Australia. The company is revolutionizing healthcare with its continuous electrolyte monitoring technology, starting with continuous potassium monitoring (akin to continuous glucose monitoring in diabetes). Its potassium monitoring platform addresses a critical challenge in cardio-kidney-metabolic disease management by enabling the safe implementation of optimal medical therapies.